| Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial K Ueki, T Sasako, Y Okazaki, M Kato, S Okahata, H Katsuyama, ... The lancet Diabetes & endocrinology 5 (12), 951-964, 2017 | 305 | 2017 |
| Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial S Kahl, S Gancheva, K Straßburger, C Herder, J Machann, H Katsuyama, ... Diabetes care 43 (2), 298-305, 2020 | 265 | 2020 |
| Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and … H Yanai, H Adachi, M Hakoshima, H Katsuyama International journal of molecular sciences 22 (17), 9221, 2021 | 244 | 2021 |
| Tofogliflozin improves insulin resistance in skeletal muscle and accelerates lipolysis in adipose tissue in male mice A Obata, N Kubota, T Kubota, M Iwamoto, H Sato, Y Sakurai, I Takamoto, ... Endocrinology 157 (3), 1029-1042, 2016 | 144 | 2016 |
| An improvement of cardiovascular risk factors by omega-3 polyunsaturated fatty acids H Yanai, Y Masui, H Katsuyama, H Adachi, A Kawaguchi, M Hakoshima, ... Journal of clinical medicine research 10 (4), 281, 2018 | 100 | 2018 |
| Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes H Hamasaki, Y Kawashima, H Katsuyama, A Sako, A Goto, H Yanai Scientific Reports 7 (1), 7041, 2017 | 95 | 2017 |
| TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass I Takamoto, N Kubota, K Nakaya, K Kumagai, S Hashimoto, T Kubota, ... Diabetologia 57, 542-553, 2014 | 94 | 2014 |
| Effects of dietary fat intake on HDL metabolism H Yanai, H Katsuyama, H Hamasaki, S Abe, N Tada, A Sako Journal of Clinical Medicine Research 7 (3), 145, 2015 | 68 | 2015 |
| Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways T Watanabe, N Kubota, M Ohsugi, T Kubota, I Takamoto, M Iwabu, ... Journal of Biological Chemistry 284 (3), 1803-1812, 2009 | 65 | 2009 |
| Exercise therapy for patients with type 2 diabetes: a narrative review H Yanai, H Adachi, Y Masui, H Katsuyama, A Kawaguchi, M Hakoshima, ... Journal of clinical medicine research 10 (5), 365, 2018 | 63 | 2018 |
| Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetes H Yanai, H Adachi, H Katsuyama, S Moriyama, H Hamasaki, A Sako World journal of diabetes 6 (1), 30, 2015 | 58 | 2015 |
| The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus M Ueyama, N Nishida, M Korenaga, K Korenaga, E Kumagai, H Yanai, ... Journal of gastroenterology 51, 370-379, 2016 | 57 | 2016 |
| Daily physical activity assessed by a triaxial accelerometer is beneficially associated with waist circumference, serum triglycerides, and insulin resistance in Japanese … H Hamasaki, M Noda, S Moriyama, R Yoshikawa, H Katsuyama, A Sako, ... Journal of diabetes research 2015 (1), 526201, 2015 | 47 | 2015 |
| Effects of six kinds of sodium-glucose cotransporter 2 inhibitors on metabolic parameters, and summarized effect and its correlations with baseline data H Yanai, M Hakoshima, H Adachi, A Kawaguchi, Y Waragai, T Harigae, ... Journal of clinical medicine research 9 (7), 605, 2017 | 38 | 2017 |
| Effects of sodium-glucose cotransporter 2 inhibitors on metabolic parameters in patients with type 2 diabetes: a chart-based analysis H Katsuyama, H Hamasaki, H Adachi, S Moriyama, A Kawaguchi, A Sako, ... Journal of Clinical Medicine Research 8 (3), 237, 2016 | 37 | 2016 |
| Sodium-glucose cotransporter 2 inhibitors: possible anti-atherosclerotic effects beyond glucose lowering H Yanai, H Katsuyama, H Hamasaki, H Adachi, S Moriyama, ... Journal of Clinical Medicine Research 8 (1), 10, 2016 | 34 | 2016 |
| Hospitalization with hypoglycemia in patients without diabetes mellitus: a retrospective study using a national inpatient database in Japan, 2008–2012 A Sako, H Yasunaga, H Matsui, K Fushimi, H Hamasaki, H Katsuyama, ... Medicine 96 (25), e7271, 2017 | 33 | 2017 |
| Associations of low-intensity resistance training with body composition and lipid profile in obese patients with type 2 diabetes H Hamasaki, Y Kawashima, Y Tamada, M Furuta, H Katsuyama, A Sako, ... PLoS One 10 (7), e0132959, 2015 | 32 | 2015 |
| Hospitalization for hypoglycemia in Japanese diabetic patients: a retrospective study using a national inpatient database, 2008–2012 A Sako, H Yasunaga, H Matsui, K Fushimi, H Hamasaki, H Katsuyama, ... Medicine 94 (25), e1029, 2015 | 32 | 2015 |
| Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label … K Ueki, T Sasako, M Kato, Y Okazaki, S Okahata, H Katsuyama, ... BMJ Open Diabetes Research and Care 4 (1), e000123, 2016 | 31 | 2016 |
